11월 25일(수)에 23시 59분까지 수강하신 강의만 평점 인정이 되며, 이 후에 강의를 들으신 경우에는 연수평점이 인정되지 않습니다.
| Date | Wednesday, Sep. 23 | Thursday, Sep. 24 | Friday, Sep. 25 | |||
|---|---|---|---|---|---|---|
| Channel | Ch. I | Ch. Ⅱ | Ch. I | Ch. Ⅱ | Ch. I | Ch. Ⅱ |
| 08:15-9:00 | Senate Meeting 평의원회 08:00-11:00 *ZOOM 화상회의 |
|||||
| I-15 (SY10C) CAP 8:15-9:30 |
Ⅱ-13 (SY10C) CAP 8:15-9:30 |
|||||
| 09:00-09:50 | I-7 (PL 02) AACC-KSLM 09:00-10:00 |
Ⅱ-6 (PL 02) AACC-KSLM 09:00-10:00 |
||||
| I-16 (SY9C) CLSI 09:30-10:30 |
Ⅱ-14 (SY9C) CLSI 09:30-10:30 |
|||||
| 09:50-10:10 | Opening Ceremony 09:50-10:10 |
Opening Ceremony 09:50-10:10 |
I-8 (EW2D) Seegene Inc. 10:00-10:40 |
Ⅱ-7 (EW2A) Roche Diagnostics Korea 10:00-10:40 |
||
| 10:10-11:10 | I-1 (PL 01) 10:10-11:10 |
Ⅱ-1 (PL 01) 10:10-11:10 |
I-17 (EW4D) SD BIOSENSOR, Inc. 10:30-11:10 |
I-15 (EW3A) LG Chem 10:30-11:10 |
||
| I-9 (SY4A) 10:40-12:10 |
Ⅱ-8 (SY2B) (Kor) 10:40-12:10 |
|||||
| 11:10-11:50 | I-2 (EW1A) Roche Diagnostics Korea 11:10-11:50 |
Ⅱ-2 (EW2B) Abbott Korea 11:10-11:50 |
I-18 (PL 03) 11:10-12:10 |
Ⅱ-16 (PL 03) 11:10-12:10 |
||
| Exhibition & E-poster Hour | ||||||
| 11:50-13:00 | Exhibition & E-poster Hour | Exhibition & E-poster Hour | ||||
| 13:00-13:40 | I-3 (KS 01) 13:00-13:40 |
Ⅱ-3 (KS 01) 13:00-13:40 |
I-10 (KS 02) 13:00-13:40 |
Ⅱ-9 (KS 02) 13:00-13:40 |
I-19 (KS 03) 13:00-13:40 |
Ⅱ-17 (KS 03) 13:00-13:40 |
| 13:40-14:20 | I-4 (EW2C) Siemens Healthineers Ltd. 13:40-14:20 |
Ⅱ-4 (EW1B) Abbott Rapid DIagnostics, Inc. 13:40-14:20 |
I-11 (EW1C) Sysmex Korea 13:40-14:20 |
Ⅱ-10 (EW4B) HANDOK Inc. 13:40-14:20 |
I-20 (EW3B) MSD Korea 13:40-14:20 |
Ⅱ-18 (EW3C) SML Genetree Co., Ltd 13:40-14:20 |
| I-5 (SY5C) 14:20-17:00 |
Ⅱ-5 (SY2C) (Kor) *지도 전문의 교육세션 14:20-18:20 |
I-12 (SY7A) AACC-KSLM 14:20-15:50 |
Ⅱ-11 (SY7B) (Kor) *감염 관리 필수 교육 14:20-16:20 |
I-21 (SY10A) 14:20-15:50 |
Ⅱ-19 (SY4B) (Kor) 14:20-15:50 |
|
| 14:20-17:00 | ||||||
| I-13 (EW1D) Beckman Coulter Korea 15:50-16:30 |
KSLM Assembly Meeting (Korean only) *ZOOM 화상회의 |
|||||
| I-14 (SY8A) 16:30-18:00 |
Ⅱ-12 (EW4A) bioMérieux KOREA 16:20-17:00 |
|||||
| 17:00-17:40 | I-6 (EW4C) QIAGEN Korea 17:00-17:40 |
|||||
| 17:40-18:20 | ||||||
| Date | Wednesday, Sep. 23 | |
|---|---|---|
| Channel | Ch. I | Ch. Ⅱ |
| 09:50-10:10 | Opening Ceremony | Opening Ceremony |
| 10:10-11:10 | I-1 (PL 01) | Ⅱ-1 (PL 01) |
| Fusobacterium nucleatum and colorectal cancer | Fusobacterium nucleatum and colorectal cancer | |
| 11:10-11:50 | I-2 (EW1A) | Ⅱ-2 (EW2B) |
| Roche Diagnostics Korea | Abbott Korea | |
| 11:50-13:00 | Exhibition & E-poster Hour | |
| 13:00-13:40 | I-3 (KS 01) | Ⅱ-3 (KS 01) |
| Genomics, metabolomics and the diagnosis of rare diseases | Genomics, metabolomics and the diagnosis of rare diseases | |
| 13:40-14:20 | I-4 (EW2C) | Ⅱ-4 (EW1B) |
| Siemens Healthineers Ltd. | Abbott Rapid DIagnostics, Inc. | |
| 14:20-17:00 | I-5 (SY5C) | Ⅱ-5 (SY2C) |
| External Quality Assurance System |
Education course for laboratory medicine specialist *지도 전문의 교육세션 |
|
| 17:00-17:40 | I-6 (EW4C) | |
| QIAGEN Korea | ||
| 17:40-18:20 | ||
| Date | Thursday, Sep. 24 | |
|---|---|---|
| Room | Ch. I | Ch. II |
| 08:00-11:00 | Senate Meeting | Senate Meeting |
| 평의원회 *ZOOM 화상회의 |
평의원회 *ZOOM 화상회의 |
|
| 09:00-10:00 | I-7 (PL 02) AACC-KSLM |
Ⅱ-6 (PL 02) AACC-KSLM |
| Clinical Lab 2.0: How the laboratory can support value based care, optimize patient outcomes, and reduce total costs of care | Clinical Lab 2.0: How the laboratory can support value based care, optimize patient outcomes, and reduce total costs of care | |
| 10:00-10:40 | I-8 (EW2D) | II-7 (EW2A) |
| Seegene Inc. | Roche Diagnostics Korea | |
| 10:40-12:10 | I-9 (SY4A) | II-8 (SY2B)(Kor) |
| Artificial intelligence for medical genetics | Education workshop for residents and new specialists in laboratory medicine | |
| 12:10-13:00 | Exhibition & E-poster Hour | |
| 13:00-13:40 | I-10 (KS 02) | Ⅱ-9 (KS 02) |
| PML-RARα: Lessons from the chimera and the curable leukemia | PML-RARα: Lessons from the chimera and the curable leukemia | |
| 13:40-14:20 | I-11 (EW1C) | Ⅱ-10 (EW4B) |
| Sysmex Korea | HANDOK Inc. | |
| 14:20-15:50 | I-12 (SY7A) AACC-KSLM |
Ⅱ-11 (SY7B) (Kor) |
| If at first you don’t succeed: An interactive case-based view of emerging molecular technologies | Technical innovation and laboratory medicine and infection control *감염 관리 필수 교육 |
|
| 15:50-16:30 | I-13 (EW1D) | |
| Beckman Coulter Korea | ||
| 16:30-18:00 | I-14 (SY8A) | Ⅱ-12 (EW4A) |
| bioMérieux KOREA | ||
| Preparedness and rapid response against pandemic COVID-19 in South Korea | ||
| Date | Friday, Sep. 25 | |
|---|---|---|
| Channel | Ch. I | Ch. Ⅱ |
| 08:15-09:30 | I-15 (SY10C) CAP |
Ⅱ-13 (SY10C) CAP |
| The challenge of laboratory-developed tests: A regulatory and legislative update | The challenge of laboratory-developed tests: A regulatory and legislative update | |
| 09:30-10:30 | I-16 (SY9C) CLSI |
Ⅱ-14 (SY9C) CLSI |
| Evidence-based laboratory management and its convergence with CLSI guidelines | Evidence-based laboratory management and its convergence with CLSI guidelines | |
| 10:30-11:10 | I-17 (EW4D) | I-15 (EW3A) |
| SD BIOSENSOR, Inc. | LG Chem | |
| 11:10-12:10 | I-18 (PL 03) | Ⅱ-16 (PL 03) |
| Measurement traceability for timeless global harmonization of clinical laboratory testing | Measurement traceability for timeless global harmonization of clinical laboratory testing | |
| 12:10-13:00 | Exhibition & E-poster Hour | |
| 13:00-13:40 | I-19 (KS 03) | Ⅱ-17 (KS 03) |
| New paradigms in the treatment of massive hemorrhage | New paradigms in the treatment of massive hemorrhage | |
| 13:40-14:20 | I-20 (EW3B) | Ⅱ-18 (EW3C) |
| MSD Korea | SML Genetree Co., Ltd | |
| 14:20-15:50 | I-21 (SY10A) | Ⅱ-19 (SY4B) (Kor) |
| Challenges to maintain an adequate blood transfusion | Inspector workshop of Korean laboratory accreditation program | |
| 15:50-16:00 | KSLM Assembly Meeting | KSLM Assembly Meeting |
| (Korean only) *ZOOM 화상회의 |
(Korean only) *ZOOM 화상회의 |
|
| Channel Ⅰ (Kor.) | Channel Ⅱ (Eng.) | ||
|---|---|---|---|
| 1 | [SY1B] Hospital transfusion management | 1 | [SY8B] Clinically unmet needs in laboratory hematology |
| 2 | [SY1C] Policy trends in laboratory medicine | 2 | [SY9A] Laboratory investigation of hormone and vitamins |
| 3 | [SY2A] Improving laboratory productivity through IT system | 3 | [SY9B] PHEIC (Public Health Emergency of International Concern) & EUA (Emergency Use Authorization) |
| 4 | [SY3B] Convergent evolution of specialists in the mid-sized hospitals | 4 | [SY10B] Practical aspects of laboratory management (Ⅷ); Clinical laboratory environment and safety |
| 5 | [SY7C] Cooperation of ministry of food and drug safety and Korean society for laboratory medicine for overcoming COVID-1 | ||
